1. Abad, Etna, Sandoz, Jérémy, Romero, Gerard, Sdelci, Sara, Janic, Ana. 2024. The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability. In Journal of experimental & clinical cancer research : CR, 43, 127. doi:10.1186/s13046-024-03045-4. https://pubmed.ncbi.nlm.nih.gov/38685100/
2. Zhang, Zhen, Zhang, Luoyan, Wang, Bin, Zhang, Yunhong, Li, Xia. 2019. RNF144B inhibits LPS-induced inflammatory responses via binding TBK1. In Journal of leukocyte biology, 106, 1303-1311. doi:10.1002/JLB.2A0819-055R. https://pubmed.ncbi.nlm.nih.gov/31509299/
3. Du, Li, Chen, Wei, Li, Chunyun, Cui, Yinghong, He, Zuping. 2022. RNF144B stimulates the proliferation and inhibits the apoptosis of human spermatogonial stem cells via the FCER2/NOTCH2/HES1 pathway and its abnormality is associated with azoospermia. In Journal of cellular physiology, 237, 3565-3577. doi:10.1002/jcp.30813. https://pubmed.ncbi.nlm.nih.gov/35699595/
4. Zhuang, Huiyu, Zhang, Zhiqiang, Wang, Wei, Qu, Hong. 2023. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis. In Tissue & cell, 86, 102277. doi:10.1016/j.tice.2023.102277. https://pubmed.ncbi.nlm.nih.gov/37992458/
5. Ariffin, Juliana K, Kapetanovic, Ronan, Schaale, Kolja, Schroder, Kate, Sweet, Matthew J. 2016. The E3 ubiquitin ligase RNF144B is LPS-inducible in human, but not mouse, macrophages and promotes inducible IL-1β expression. In Journal of leukocyte biology, 100, 155-61. doi:10.1189/jlb.2AB0815-339R. https://pubmed.ncbi.nlm.nih.gov/26819317/
6. Zhou, Qing, Eldakhakhny, Sahar, Conforti, Franco, Melino, Gerry, Sayan, Berna S. 2018. Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation. In Cell death & disease, 9, 504. doi:10.1038/s41419-018-0521-1. https://pubmed.ncbi.nlm.nih.gov/29724995/
7. Wang, C-B, Wang, Y, Wang, J-J, Guo, X-L. . LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p. In European review for medical and pharmacological sciences, 24, 1007-1022. doi:10.26355/eurrev_202002_20151. https://pubmed.ncbi.nlm.nih.gov/32096180/